Pharming Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	2.85	-11.84	-10.55	13.67	16
Depreciation & Amortization	10.32	10.19	10.13	9.33	9.17
Other Amortization	0.89	0.85	0.88	-	-
Loss (Gain) From Sale of Assets	-	-	-21.28	-	-
Asset Writedown & Restructuring Costs	-	5.03	4.92	3.86	10.44
Loss (Gain) From Sale of Investments	-2.35	-4.99	0.93	-11.06	-0.11
Loss (Gain) on Equity Investments	-0.62	1.76	0.29	1.08	-0.69
Stock-Based Compensation	13.77	11.25	9.25	6.39	9.06
Other Operating Activities	19.46	-3.97	5.09	-0.44	-1.05
Change in Accounts Receivable	-3.36	-6.78	-18.54	2.36	5.92
Change in Inventory	-1.29	-0.5	-14.43	-15.02	-6.15
Change in Accounts Payable	14.13	-2.77	16.23	11.99	-5.19
Change in Other Net Operating Assets	0.9	-0.02	-0.22	0.27	0.47
Operating Cash Flow	54.71	-1.8	-17.3	22.46	37.84
Operating Cash Flow Growth	-	-	-	-40.65%	-54.75%
Capital Expenditures	-0.75	-0.79	-1.44	-1.38	-10.74
Cash Acquisitions	-57.48	-	-	-	-
Sale (Purchase) of Intangibles	-0.01	-0.01	21.25	-0.6	-5.98
Investment in Securities	84.48	32.41	-149.2	7.3	-4.59
Other Investing Activities	-0	-	-	-	-
Investing Cash Flow	26.25	31.62	-129.39	5.32	-21.31
Long-Term Debt Issued	-	104.54	-	-	-
Long-Term Debt Repaid	-4.25	-138.93	-4.04	-3.31	-3.22
Net Debt Issued (Repaid)	-4.25	-34.39	-4.04	-3.31	-3.22
Issuance of Common Stock	19.81	5.58	8.13	2.28	4.72
Other Financing Activities	-14.07	-5.6	-5.13	-3.95	-29.45
Financing Cash Flow	1.5	-34.41	-1.04	-4.98	-27.95
Foreign Exchange Rate Adjustments	7.91	-2.21	2.13	-7.38	-1.83
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-
Net Cash Flow	90.36	-6.8	-145.6	15.42	-13.24
Free Cash Flow	53.96	-2.59	-18.74	21.08	27.1
Free Cash Flow Growth	-	-	-	-22.21%	-65.68%
Free Cash Flow Margin	14.35%	-0.87%	-7.64%	10.25%	13.63%
Free Cash Flow Per Share	0.07	-0.00	-0.03	0.03	0.04
Cash Interest Paid	6.2	5.6	5.13	3.95	4.45
Cash Income Tax Paid	4.6	15.58	0.66	1.24	-
Levered Free Cash Flow	68.65	0.24	8.06	16.23	-17.14
Unlevered Free Cash Flow	75.35	5.7	11.78	19.58	-13.33
Change in Working Capital	10.39	-10.07	-16.96	-0.39	-4.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.